MAPK14 and breast neoplasm: Cat K-induces platelet aggregation in a dose-dependent manner and triggers Src and p38 phosphorylation and Ca2+ influx from the contents of platelets inducing platelet dysfunction, which could facilitate the interaction with breast tumor cells.